Four companies announce new CFOs

Four companies, Immunocore Holdings plc (NASDAQ:IMCR),  Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), Caribou Biosciences Inc. (NASDAQ:CRBU) and Karyopharm Therapeutics Inc. (NASDAQ:KPTI) announced new CFOs. 

Immunocore, a pioneer in TCR bispecific therapies, named Travis Coy to the role. Coy, whose full title is EVP, CFO and head of corporate development, became a non-executive director at Immunocore in 2019 and was most recently VP, head of transactions and M&A, corporate business development at Eli Lilly and Co. (NYSE:LLY)...